Schedule 13G ownership disclosure

Celldex Therapeutics Inc

COMMON STOCK · CUSIP: 15117B202

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • FMR LLC

    Shares: 4,857,668.00 · Class: 7.3%

  • Abigail P. Johnson

    Shares: 4,857,668.00 · Class: 7.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000315066-25-000856
Form type
SCHEDULE 13G/A
Filer
Celldex Therapeutics, Inc.
CIK
CIK 744218
Filed
Feb 12, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub